The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Microsaic Creditor; Update

19 Apr 2023 13:21

RNS Number : 7936W
Deepverge PLC
19 April 2023
 

19 April 2023

 

DeepVerge plc

 

("DeepVerge" or "the Company" or "the Group")

 

Microsaic Creditor; update

 

DeepVerge (AIM: DVRG), the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins, notes the notification issued by Microsaic Systems plc ("Microsaic") on 18 April 2023.

DeepVerge confirms that amounts are currently owed by DeepVerge group companies to Microsaic totalling approximately £1.4 million.

DeepVerge also confirms that a settlement plan ("Settlement Plan") has been proposed to Microsaic, the terms of which are substantially agreed, and that it has made an initial payment in line with that plan. In addition, DeepVerge confirms that Microsaic has continued to supply services to DeepVerge during 2023, and all amounts arising during the current financial year continue to be paid under normal 30 day terms, in line with commercial agreements between the two parties.

DeepVerge shares a common director, Nigel Burton, with Microsaic, and finalisation of the Settlement Plan will fall to be treated as a related party transaction, and will require notification, under AIM Rule 13.

DeepVerge currently expects this agreement to be agreed in due course - and until that point it is able to, and will continue to, pay amounts in line with the Settlement Plan as proposed.

Further to commentary in the Company's 17 April 2023 notification, at present the working capital position of DeepVerge is such that the sum total of its trade receivables (net of impairments) and cash balances together exceed the sum total of its trade creditors and other payable balances (with the amounts owing to Microsaic set out above included in this).

In addition, the Company has agreed payment plans, or payment phasings, with substantially all its creditors.

The Company is exploring funding options including trade finance as a stronger balance sheet would enable the Company to accelerate delivery of some existing contracts and increase confidence in seeking new business.

The Company will issue further announcements as required in line with the AIM Rules for Companies.

ENDS

 

DeepVerge plc

Nigel Burton, Interim CEO

+44 (0) 7785 234447

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins; Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAALNFAEDEFA
Date   Source Headline
21st Oct 20217:00 amRNS2nd Generation Microtox® PD equipment shipping
15th Oct 20217:00 amRNSRelated Party Transaction
6th Oct 20217:00 amRNSDVRG engages with Media.Monks re Skin Trust Club
20th Sep 20217:00 amRNSSponsor at Reuters Conference on Climate Change
15th Sep 20217:01 amRNSIndia Centre of Excellence for Modern Water AMBC
15th Sep 20217:00 amRNSInterim Results
3rd Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Aug 20217:00 amRNSContinued progress thru' Microsaic collaboration
26th Jul 202112:25 pmRNSResult of AGM
26th Jul 20217:00 amRNSUpdate
12th Jul 20217:00 amRNSAppointment of Group Marketing Officer
7th Jul 20211:16 pmRNSExercise of Options and Total Voting Rights
30th Jun 20215:28 pmRNSNotice of AGM
30th Jun 20215:28 pmRNSFinal Results
25th Jun 20212:55 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSMicrotox Successful Phase 3 Field Trials
23rd Jun 20211:15 pmRNSResult of General Meeting
7th Jun 202112:23 pmRNS£10m Firm /Cond'l Placings & Subs - replacement
7th Jun 20219:35 amRNSFirm & Cond'l Placings & Subscription for £10m
6th May 20217:00 amRNSNew AI centre of excellence in Cork
30th Apr 20215:25 pmRNSExercise of Warrants and Total Voting Rights
30th Apr 20217:00 amRNSExercise of Warrants and Total Voting Rights
28th Apr 20217:00 amRNSDeepVerge signs MoU for JV with China Resources
26th Apr 20217:00 amRNSSkin Trust Club iOS App goes live
22nd Apr 20212:05 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:01 pmRNSPrice Monitoring Extension
21st Apr 20213:00 pmRNSExercise of Warrants and Total Voting Rights
13th Apr 20212:34 pmRNSExercise of Warrants and Total Voting Rights
13th Apr 20217:00 amRNSDirector/PDMR Shareholding
7th Apr 20213:43 pmRNSExercise of Options and Total Voting Rights
31st Mar 20217:00 amRNSUpdates on Labskin, Modern Water, Skin Trust Club
25th Mar 20213:43 pmRNSDeepVerge Investor Presentation
24th Mar 20213:37 pmRNSExercise of Warrants and Total Voting Rights
24th Mar 20212:05 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNS3 year Technology & Comm'l Agreem't with Microsaic
23rd Mar 20219:48 amRNSExercise of Warrants and Total Voting Rights
17th Mar 20214:22 pmRNSExercise of Warrants and Total Voting Rights
17th Mar 20217:00 amRNSMicrotox® BT Eval'n of SARS-CoV-2 from breath test
12th Mar 202111:23 amRNSAward Nomination in China
8th Mar 20214:35 pmRNSPrice Monitoring Extension
8th Mar 20217:00 amRNSChange of interests of significant shareholder
5th Mar 20213:05 pmRNSExercise of Warrants and Total Voting Rights
2nd Mar 20217:00 amRNSEcowaterOS and Microtox PD Event in China
26th Feb 202112:11 pmRNSExercise of Warrants and Total Voting Rights
17th Feb 20217:00 amRNSProd'n orders worth $5m for Modern Water Equipment
15th Feb 20217:00 amRNSProposed Framework Services Ag'ment with Microsaic
10th Feb 20217:00 amRNSDeepverge adds two virus containment laboratories
8th Feb 20217:00 amRNSDirector/PDMR Shareholding
1st Feb 20215:45 pmRNSExercise of Warrants and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.